Strengthening the National HIV Response


The Newlands Clinic (NC) is a national Centre of Excellence for the comprehensive care of HIV patients with complex and advanced diseases. Through its training centre and research capacities it informs and strengthens Zimbabwe’s national HIV response. Managed by the Swiss Ruedi Lüthy Foundation, Switzerland’s support to the Newlands Clinic contributes to Switzerland’s visibility and excellent reputation in the country. 

Pays/région Thème Période Budget
Zimbabwe
Santé
Education
nothemedefined
Maladies sexuellement transmissibles (y compris VIH/sida)
Santé & droits reproductives
Equipements scolaires et formation
Éducation sanitaire
15.06.2023 - 31.12.2028
CHF  3’815’000
Contexte Zimbabwe remains amongst the countries with the highest HIV prevalence rate worldwide for the age group of 15 to 49 years (11.6% in 2021). The country struggles to address the crisis, with inadequate public resources to provide quality services to the poor, and a shortage of health workers to deliver quality care and treatment. Thanks to Swiss support, over the past 20 years the Newlands Clinics has evolved into a centre of excellence for the comprehensive care of AIDS patients in Zimbabwe. Financially, the clinic remains heavily dependent on Swiss privat and public donations, and the NC’s costly treatment model limits its potential for replicability and scale up. Stepping up private sector engagement and accessing in-country funds will become essential for NC to ensure the viability of its operations. 
Objectifs To improve the quality of life of people living with HIV/AIDS and reduce morbidity, mortality, and transmission of HIV in Zimbabwe.
Groupes cibles
  • Adult women, men, adolescents and children affected by HIV/AIDS
  • Doctors and nurses
  • Public and private clinics and hospitals
Effets à moyen terme
  • Increased capacity built for OI/ART1 service delivery and task sharing through training, clinical attachment, mentorship, and rolling out components of the NC model of best practice
  • Increased survival and reduced mortality of 9,000 patients receiving treatment and care at NC
  • Influencing national and international policies and guidelines for the comprehensive management of people living with HIV and Aids through evidence-based research findings
Résultats

Principaux résultats attendus:  

  • 9000 OI/ART patients in care by 2028
  • 10 provinces supported with training and mentorship
  • 5331 HCWs trained in Advanced HIV Management by 2028
  • 9200 HCWs trained by 2028 in HIV related short courses and mentorship
  • 850 girls immunised for HPV per year
  • 3200 women screened for cervical cancer per year by 2028
  • 1000 women receiving access to modern methods of family planning services
  • Viability of operations strenghtened through diversification of partners/donors


Principaux résultats antérieurs:  

  • 4076 Health Care Workers have been trained between 2020-2023 on HIV Management (advanced and basic courses)
  • One Continued Medical Education meeting held at a provincial Hospital for the local Health Care Workers in 2022
  • 7720 patients in care at the NC (2022), following a steady increase since 2016 (5776), with a very low mortality rate of 1% (70 patients)
  • The NC’s Mental and Social Health Department provided counselling to 1050 referred patients
  • 2286 women were screened for cervical cancer in 2022
  • The enrolment of patients with complex diseases and third-line patients significantly increased the cost of comprehensive care and will likely further increase the mortality and morbidity rates


Direction/office fédéral responsable DDC
Crédit Coopération au développement
Partenaire de projet Partenaire contractuel
Secteur privé
Organisation suisse à but non lucratif
  • Autre organisation suisse non-profit
  • Sectreur privé étranger Sud/Est
  • Secteur privé suisse
  • Ruedi Lüthy Foundation


Coordination avec d'autres projets et acteurs SDC supported Programmes: Zvandiri Programme, O3+, Future Life Now Others: Global Fund to fight AIDS, TB and Malaria, Health Resilience Fund
Budget Phase en cours Budget de la Suisse CHF    3’815’000 Budget suisse déjà attribué CHF    764’575 Budget y compris partenaires de projet CHF    34’800’000 Projet total depuis la première phase Budget de la Suisse CHF   0
Phases du projet Phase 1 15.06.2023 - 31.12.2028   (Phase en cours)